NAS10029,813+0.55%S&P7,744+0.28%GOLD$4,077+0.07%BTC$81,598+0.98%VIX16.87−3.71%latest tape · as of 20:04 UTC
The Screen · Financials · Banks - Diversified
CCitigroup
C · a US exchange · USD · Market cap $206.7B · 224,000 employees
Citigroup Inc., a diversified financial service holding company, provides various financial products and services to consumers, corporations, governments, and institutions.
FAIL · Does not pass the screen
120.62 USD
Price as of 23 Oct 2026Daily close, not a live quoteLast reviewed 5 days ago
Screened 2026-10-23 · the tape above runs as of 20:04 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
Price120.62 USD at the 23 Oct 2026 close
Our ratingAvoid, current read distribution
Ethical screenDoes not pass
OptionsOpen interest leans slightly to calls (put/call 0.78)
Last reviewed23 Oct 2026 (5 days ago)
A summary of the dated readings below, not a live quote and not advice.
PRICE · FAIR-VALUE RANGE1M3M6MYTD1Y3Y5Y
What this means: price 120.62 against the desk's fair-value range, base estimate 170.00, over the last year.
Positioning political selling, disclosed 2026-09-24
Options put/call open interest 0.78, read 2026-10-27
Ethical does not pass the values gate
Price120.62 USD
Fair value170.00
Ethical score10.0/100
RatingAVOID
Our investment reviews on this name
2026-10-20Read Distribution123.21-2.1% to today ✓Markdown gives way to Distribution after an 8% slide in 3 weeks
2026-10-02Read Markdown134.28-10.2% to today ✓Accumulation gives way to Markdown first Markdown read since July
2026-08-24Read Accumulation129.67-7.0% to today Markdown gives way to Accumulation
2026-07-02Read Markdown132.47-8.9% to today ✓First review on file: Markdown
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Citigroup holds its Distribution at $120.62. The statistical read favours the sellers, held for 124 days.
As held on the ledger · 2026-10-23
Phase
Distribution · caution
Quantitative state
The statistical read favours the sellers, held for 124 days
Price at the screen
$120.62
Valuation
12.24 trailing · 9.42 forward price to earnings
Values screen
FAIL· score 10.0
Beta
1.11
The Workings
Five Screens, Shown in Full
Does not pass. Business activity screen
Test
Figure
Limit
What it means
Status
Business activity
Excluded
Core business clean
Business activity: Financials sector
Fail
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Citigroup does not clear the screen at the business-activity stage. It operates in conventional financial services, which the screen treats as interest-based, so the financial ratios are not the deciding factor here.
Read as at 2026-10-27. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when C's ethical verdict changes
Today C does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Conscience Overlay
Conscience flag · BDS Movement
The quantitative screen above is arithmetic. Separately, community boycott lists cite this company: Cited by BDS movement for banking relationships and investment services connected to Israeli government entities and settlement-linked companies. The desk records that flag here without folding it into the verdict: the screen measures the balance sheet, the overlay informs the conscience, and they are different judgements that belong to different owners. The second one is yours.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads AVOID: it trades at roughly a 38% discount to our $170.00 fair value, narrow competitive moat, 8.00% revenue growth.
Fair value range in USD, drawn from the 2026-10-23 screen. The gold marker is the market price at the same screen. A 38.0% margin of safety to the base estimate.
Third-party analyst targets: 21 covering, consensus Buy. The average target sits +28% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-23 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
The Financial Giant That Falls Short Ethically
When you think of banking services, a behemoth like Citigroup might come to mind, a company that offers a vast array of financial products to a diverse clientele. However, despite its size and scope, Citigroup fails to meet our ethical standards, and that's why we're steering clear.
Citigroup's financial performance isn't the issue; with a forward P/E of 10.1x, it's trading at a discount to its peers, and boasts a 16% revenue growth and a 22% profit margin. The question mark is its narrow moat and a 9% ROE, which suggests a less competitive edge and subpar returns on equity.
Yet, the real reason we avoid Citigroup lies in its ethical shortcomings. Despite the consensus buy rating from 20 analysts and a median target of $158, our ethical screen shows a fail, specifically on the business activity screen. This means that while the numbers might look appealing, the underlying activities of the company do not align with our strict ethical criteria.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
C trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-27Distribution$123.21+0.0%Entry 12
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 75%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (21 analysts) rates it buy, with a mean price target of $151.
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 5.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 75%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (21 analysts) rates it buy, with a mean price target of $151.
2026-10-13Markdown$129.64+0.0%Entry 10
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 16% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 75%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (21 analysts) rates it buy, with a mean price target of $152. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-12Markdown$129.64-3.5%Entry 9
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 3.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 16% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 75%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (20 analysts) rates it buy, with a mean price target of $153. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-11Markdown$134.28+0.0%Entry 8
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 16% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 75%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (20 analysts) rates it buy, with a mean price target of $153. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-10Markdown$134.28+0.0%Entry 7
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 16% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 75%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (20 analysts) rates it buy, with a mean price target of $153. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-02Markdown · changed$134.28+3.6%Entry 6
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 3.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 16% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 75%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (20 analysts) rates it buy, with a mean price target of $155.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 0.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 16% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 75%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (21 analysts) rates it buy, with a mean price target of $147.
2026-07-24Markdown$129.36-2.3%Entry 4
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 2.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 16% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 75%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (21 analysts) rates it buy, with a mean price target of $147.
2026-07-18Markdown$132.47+0.0%Entry 3
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 16% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 75%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (21 analysts) rates it buy, with a mean price target of $147.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.